Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

View Plans
Sign in to unlock report generation

Medicine results for "TETANUS TOXOID" 15 medicines in Tanzania

Price column visibility: locked (sign in required)

Page 1 of 1

BETT

TZ 16 H 0004 Tetanus Toxoid 0.5 ml/vial
Details

SII Tetanus Toxoid Adsorbed

TAN 05,685 J07A SER Purified Tetanus Toxoid >5 (> 40 IU) IU
Details

Adsorbed Tetanus Vaccine BP

TZ 16 H 0004 Tetanus Toxoid NLT 40 IU/0.5 ml
Details

Nimenrix vaccine

TZ 16 H 0230 1conjugated to tetanus toxoid carrier protein 44 mcg/ml,Neisseria meningitidis group A polysaccharide1 5 mcg/ml,Neisseria meningitidis group C polysaccharide1 5 mcg/ml,Neisseria meningitidis group W-135 polysaccharide1 5 mcg/ml,Neisseria meningitidis group Y polysaccharide1 5 mcg/ml
Details

Typbar TCV

TZ 19 H 0340 Purified VI - Capsular Polysaccharide of Salmonella Typhi Ty2 conjugated to Tetanus toxoid 25 mcg/ml
Details

Abhay TOX

TAN 24 V 0157 Aluminium Phosphate (AlPO4) as Al+++ ≤ 1.25 mg/6 mL,Saline q.s to 0.5 /ml,Tetanus Toxoid >40 IU (5 to 25 Lf) IU/0.5ml,Thiomersal 0.01% w/v
Details

Easyfive-TT

TZ 16 H 0237 Diphtheria Toxoid 30 IU,Haemophilus influenza Type-b conjugate 10 mcg/ml,Hepatitis B Surface Antigen (rDNA) 10 mcg/ml,Pertusis (Whole cell) 4 IU,Tetanus Toxoid 60 IU
Details

EupentaTM

TAN 24 HM 0216 Diptheria Toxoid 15 Lf/0.5ml,Haemophilus influenza Type-b conjugate 30~50 µg/0.5ml,Hepatitis B Surface antigen 10 µg/0.5ml,Pertusis (Whole cell) >4 IU/ml,Tetanus Toxoid 10 Lf/0.5ml
Details

ComBe Five liquid

TZ 16 H 0219 B. pertussis (Whole Cell) 16 OU ( _> 4 IU),Diphtheria Toxoid 25 Lf ( _> 30 IU),Purified Capsular Polysaccharide of Hib (PRP) covalently linked to 20 to 36.7 mcg of Tetanus Toxoid 11 mcg,Tetanus Toxoid 5.5 Lf ( _> 60 IU),r-HBsAg 12.5 mcg
Details

Vaxtar-5

TAN 23 V 0547 Diphtheria Toxoid > 30IU (> 20 Lf to < 30Lf) IU,Hepatitis B Surface Antigen (rDNA) >10 IU,Hib Polysaccharide covalently bound to TT (PRP-TT) >10 IU,Inactivated Whole cell Bordetella Pertussis > 4 IU IU,Tetanus Toxoid >60IU (>5Lf to < 25Lf) IU
Details

ComBe Five

TZ 16 H 0219 Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed). 5 ml,Hepatitis B Surface antigen protein 12.5 IU,Pertusis (Whole cell) 16 Lf/0.5ml,Purified Capsular Hib polysaccharide 11 IU,Tetanus Toxoid 5.5 q.s to 3.0ml
Details

DTPHH

TZ13H210 Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Bulk Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) LF,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
Details

DTPHH Vaccine

TZ13H211 Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) Lf/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
Details

Diphtheria Tetanus Pertussis (Whole Cell) Hepatitis B (rDNA) and Haemophilus type b conjugate vaccin

TZ 15 H 0237 Aluminium Phosphate 1.25 mg,B-Pertusis (whole cell) >=16 Lf/0.5ml,Diptheria Toxoid >=25 CCU50,Hepatitis B Surface Antigen (rDNA) 12.5 cc,Purified Capsular Hib polysaccharide 11 ng,Tetanus Toxoid >=5.5 CCU50,Thiomersal 0.01 g/drop
Details

Hexaxim

TAN 20 HM 0426 Diphtheria Toxoid 20 IU,Filamentous Haemagglutinin (FHA) 25 mcg,Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate) 12 mcg,Hepatitis B Surface antigen 10 mcg,Inactivated Poliemyelitis Vaccine Type 1 (Mahoney) 40 D-Antigen units,Inactivated Poliomyelitis Vaccine Type 2 (MEF-1) 8 D-Antigen units,Inactivated Poliomyelitis Vaccine Type 3 (Saukett) 32 D-Antigen units,Pertusis Toxoid (PT) 25 mcg,Tetanus Toxoid 40 IU
Details

Elsewhere on MedStatus

"TETANUS TOXOID" also matches these in Tanzania.

Active ingredients

5+

1conjugated to tetanus toxoid carrier protein 44 mcg/ml,Neisseria meningitidis group A polysaccharide1 5 mcg/ml,Neisseria meningitidis group C polysaccharide1 5 mcg/ml,Neisseria meningitidis group W-135 polysaccharide1 5 mcg/ml,Neisseria meningitidis group Y polysaccharide1 5 mcg/ml

1 product

Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Bulk Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) LF,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %

1 product

Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) Lf/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %

1 product

Aluminium Phosphate (AlPO4) as Al+++ ≤ 1.25 mg/6 mL,Saline q.s to 0.5 /ml,Tetanus Toxoid >40 IU (5 to 25 Lf) IU/0.5ml,Thiomersal 0.01% w/v

1 product

Aluminium Phosphate 1.25 mg,B-Pertusis (whole cell) >=16 Lf/0.5ml,Diptheria Toxoid >=25 CCU50,Hepatitis B Surface Antigen (rDNA) 12.5 cc,Purified Capsular Hib polysaccharide 11 ng,Tetanus Toxoid >=5.5 CCU50,Thiomersal 0.01 g/drop

1 product